WAM
IBB icon

WNY Asset Management’s iShares Biotechnology ETF IBB Stock Holding History

WNY Asset Management’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,483
Closed -$216K – 230
2024
Q3 		$216K Hold
1,483
– – 0.03% 217
2024
Q2 		$204K Hold
1,483
– – 0.03% 226
2024
Q1 		$203K Buy
+1,483
New +$203K 0.03% 226
2022
Q2 		– Sell
-1,682
Closed -$219K – 170
2022
Q1 		$219K Hold
1,682
– – 0.07% 151
2021
Q4 		$258K Sell
1,682
-580
-26% -$89.8K 0.08% 137
2021
Q3 		$367K Buy
2,262
+930
+70% +$157K 0.13% 109
2021
Q2 		$218K Sell
1,332
-75
-5% -$11.6K 0.08% 142
2021
Q1 		$212K Buy
+1,407
New +$223K 0.08% 129

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

WNY Asset Management's IBB Position: Q4 2024 in Review

WNY Asset Management sold out of iShares Biotechnology ETF (IBB) in Q4 2024, closing a stake of 1,483 shares — an estimated $216K sold.

WNY Asset Management first reported a position in IBB in Q1 2021 and held it in 8 quarters. The position peaked at $367K in Q3 2021. 874 funds tracked by Wall St. Rank hold IBB as of Q4 2024.

  • WNY Asset Management reported no remaining iShares Biotechnology ETF position as of Q4 2024 after selling out during the quarter.
  • WNY Asset Management sold 1,483 iShares Biotechnology ETF shares in Q4 2024, an estimated $216K.
  • WNY Asset Management first reported a position in iShares Biotechnology ETF in Q1 2021 and held it in 8 quarters.
  • WNY Asset Management's iShares Biotechnology ETF position peaked at $367K in Q3 2021.
  • 874 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2024.

Based on WNY Asset Management's 13F filing for Q4 2024, filed 21 Feb 2025.